Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers.
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers. Dermatology. 2009; 219(1):48-53.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
CD11 Antigens
Dermatologic Agents
Etanercept
Female
Humans
Immunoglobulin G
Infliximab
Male
Middle Aged
Psoriasis
Receptors, Tumor Necrosis Factor
Treatment Failure
Treatment Outcome
Tumor Necrosis Factor-alpha
Young Adult
authors with profiles
Mark Talamonti